Aethlon Medical Inc.
AEMD | NASDAQ
$6.79
+$0.47 (+7.44%)
Sep 22, 2026, 12:00 PM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 30, 2026 | FY 2025 Mar 30, 2025 | FY 2024 Mar 30, 2024 | FY 2023 Mar 30, 2023 | FY 2022 Mar 30, 2022 | FY 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | 574.25K | 294.17K | 659.1K |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | 574.25K | 294.17K | 659.1K |
Operating Income | -7.29M | -9.34M | -12.64M | -11.9M | -10.42M | -7.89M |
Interest Income | 156.53K | 298.12K | 428.39K | 10.97K | n/a | n/a |
Pretax Income | -7.15M | -13.39M | -12.21M | -12.03M | -10.42M | -7.89M |
Net Income | -7.15M | -13.39M | -12.21M | -12.03M | -10.42M | -7.89M |
Selling & General & Admin | 7.29M | 9.34M | 12.64M | 12.47M | 10.72M | 8.55M |
Research & Development | 1.91M | 2.21M | 2.52M | 2.75M | 2.34M | 2.07M |
Other Expenses | -1.91M | -2.21M | -2.52M | -2.75M | -2.34M | -2.07M |
Operating Expenses | 7.29M | 9.34M | 12.64M | 12.47M | 10.72M | 8.55M |
Interest Expense | 14.37K | 10.11K | n/a | n/a | n/a | 1.58K |
Selling & Marketing Expenses | 3.25M | 4.3M | 5.63M | 4.96M | 5.03M | 3.65M |
Cost & Expenses | 7.29M | 9.34M | 12.64M | 12.47M | 10.72M | 8.55M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 673K | 156K | 31K | 25K | 18K | 15K |
Shares Outstanding (Diluted) | 673.95K | 156.09K | 31.41K | 25.67K | 18.45K | 15.11K |
EPS (Basic) | -10.61 | -85.77 | -388.67 | -468.60 | -564.68 | -521.81 |
EPS (Diluted) | -10.61 | -85.77 | -388.67 | -468.60 | -564.68 | -521.81 |
EBITDA | -6.81M | -13.04M | -11.85M | -11.79M | -10.3M | -7.85M |
EBIT | -7.14M | -13.38M | -12.21M | -12.03M | -10.42M | -7.89M |
Depreciation & Amortization | 323.65K | 339.56K | 359.06K | 240.89K | 123.69K | 39.94K |
Add to Watchlist
Select watchlists to add or remove AEMD